
Zhiyong U. Wang
Articles
-
Jan 13, 2025 |
mdpi.com | Mingyuan Wang |Tong Zhang |Yanping Yuan |ZhiYong Wang |Zhiyong U. Wang
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Dec 20, 2024 |
mdpi.com | ZhiYong Wang |Zhiyong U. Wang
4. Materials and Methods 4.1. Gene CharacterizationThe protein sequence of YDSPHK1 was compared with other species using the NCBI BLAST tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 15 August 2023). Homologous sequences were downloaded and aligned using ClustalW (https://www.ebi.ac.uk/Tools/msa/clustalo/, accessed on 25 August 2023.). The conserved domains were predicted using SMART (http://smart.embl-heidelberg.de, accessed on 25 August 2023).
-
Oct 16, 2024 |
biorxiv.org | Xindong Wang |Han Lv |ZhiYong Wang |Zhiyong U. Wang |Xian Wang
AbstractGlioblastoma (GBM) is an aggressive brain tumor with limited treatment options and a poor prognosis. Tumor Treating Fields (TTF) therapy, which uses alternating electric fields to disrupt cancer cell division, has emerged as a promising non-invasive treatment. However, the development and optimization of TTF systems remain challenging, with limited studies detailing the design and practical application of such systems.
-
Jul 29, 2024 |
dx.doi.org | Ming Gao |Wei Wei |ZhiYong Wang |Zhiyong U. Wang |Zhi Yu
-
Jul 28, 2024 |
onlinelibrary.wiley.com | ZhiYong Wang |Zhiyong U. Wang |Guoliang Wang |Peng Zhao |Ping Sun
1 BACKGROUND Hepatocellular carcinoma (HCC) is one of the most common types of cancer and is also the third leading cause of cancer-related deaths.1 HCC is the predominant liver cancer subtype and accounts for 80% of the total liver cancer burden worldwide.2 Currently, several therapeutic strategies, such as surgical resection, liver transplantation, localized therapy, and systemic therapy, have been shown to be effective in controlling HCC, but these treatment modalities fail to provide...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →